Blue Horseshoe Stocks: Options Review

Options Recap

We wrapped up last week on Friday morning’s report with a pair of fresh options ideas. We are happy to start off this new trading week with a review of the solid performances of those plays, and the subsequent gain opportunities they provided for us.

Paypal, Inc. PYPL -  Paypal stock saw early gains thanks to solid numbers from its Venmo quick pay platform contained in its quarterly report. It caused us to signal interest in the PYPL Weekly $81-83 Calls and sure enough, we saw some nice chances for single-session profits.

$81 Calls – Range: 2.07-5.15 - Max Gain: 149%
$82 Calls – Range: 1.23-4.30 – Max Gain: 250%
$82.50 Calls – Range: .95-3.72 - Max Gain: 292%
$83 Calls – Range: .54-3.23 – Max Gain: 498%
____

The Procter & Gamble Co. PG- Procter and Gamble also reported on its earnings Friday morning,and recorded five year highs in sales growth. We highlighted the PG Weekly $82-84.50 Calls and swept the range with solid results there as well.

$82 Calls – Range: 2.87-5.40 – Max Gain: 88%
$82.50 Calls – Range: 2.61-5.20 - Max Gain: 99%
$83 Calls – Range: 1.70-4.70 – Max Gain: 176%
$83.50 Calls – Range: 1.80-4.14 – Max Gain: 130%
$84 Calls – Range:.96-3.49 – Max Gain: 264%
$83.50 Calls – Range: 1.05-3.15 – Max Gain: 200%
____

Fresh Options Idea:
PetMed Express, Inc. PETS 12/21 $30-35 Calls


Extended Watchlist: 
YY, MYSZ, VTVT, CLDC, APHB, RMBS, APHB(Bottom play)

Blue Horseshoe Stocks: Big Week for Options

Morgan Stanley MS – Recap

Earlier in the week we highlighted a pair of options calls in the Morgan Stanley chain following the company’s Q3 earnings report on Tuesday, in which it reported a solid beat of Wall Street expectations on profits.

As a result, the MS Weekly $43.50 & $44 Calls that we signaled in our report produced some very nice chances for traders to lock in multi-bag profits.

The $43.50 Calls, from their low of 1.32 reached 4.20, for an intraweek gain of 218% The $44 Calls low came in at .85, and it went on to log a high of 3.65. That worked out to an overall increase of 329%


Fresh Options Ideas

Paypal, Inc. PYPL - The first of our earnings related options ideas to close out the week is going to be Paypal, whose stock saw early gains on the heels of the company’s report which entailed a big boost from the company’s Venmo offshoot. Revenue streams have been growing as Paypal has launched several initiatives within the platform. We are going to be looking at the PYPL Weekly $81-83 Calls* as we close out the trading week.

The Procter & Gamble Co. PG – We’re also looking at PG, which reported on its earnings this morning, and posted it’s biggest growth in sales for the last half a decade. Our idea for this particular play will be the PG Weekly $82-84.50 Calls*

*Please do not attempt to trade options with a weekly expiration on a Friday unless you are an advanced level trader with disposable funds. It’s an extreme risk/reward proposition!


Extended Watchlist: 
CLF, NIHD, TTGT, JMU, YNDX, CGA, CCL

Incoming search terms:

  • smallests3t

Blue Horseshoe Stocks: Options Review

The Boeing Co. BA

Yesterday morning’s premarket report featured a range of calls in the Boeing options chain, after the company’s quarterly report yielded a number of positive factors. To attempt to take advantage of the activity, we signaled the BA Weekly $352.50-360 Calls.

While the stock didn’t have an eye-popping session by any means, the moves it did make facilitated some good intraday opportunities early on, and later in the day, some even better ones. Below are the best moves made by each of our tracked calls on the day:

$352.50 Calls – Range: 2.87-5.00 – Max Gain: 74%
$355 Calls – Range: 1.90-3.94 – Max Gain: 107%
$357.50 Calls – Range: 3.00-5.52 – Max Gain: 84%
$360 Calls – Range:  .67-1.93 – Max Gain: 188%


Mastercard, Inc. MA

To keep the options train rolling, we’re going to signal some calls in Mastercard, which, oddly enough, is a stock we’ve never mentioned in our reports.

It has been building a steady run up the chart for essentially the past two years, and is currently pushing its way further into blue skies following a strong quarterly showing.

We’re sure MA has long-term potential, but we’re more interested in taking advantage of the immediate situation, so we want to signal the MA Weekly $170-175 Calls for observation.


Extended Watchlist:
AAPL, BPMX, CORT, OPGN, PYPL

Blue Horseshoe Stocks: Fresh Options Ideas & More

First we’d like to apologize for our email list members for the absence of yesterday’s premarket report. Our service provider was shut down for the most of the day rendering us unable to send our daily report via email. This is an exceedingly rare event, but in these cases, you can always bookmark and visit BlueHorseshoeStocks.com just before market open, as all of our newsletters are archived there for easy reference.

Alcobra Ltd. ADHD

We did include ADHD in yesterday’s report, but since many of readers happened to miss it, we’ll back up to the next most recent mention, when we alerted the stock on September 29th.

The stock did see sub-1.00 prices that day, but took a couple more sessions to see its low of .96. Since then ADHD has been on a steady run-up, culminating in a new high of 2.17, which represented a very nice 127% move in a three week period.


PayPal Holdings, Inc. PYPL

We want to highlight a range of options for PYPL after the company posted its quarterly earnings after market close yesterday. The stock has been on a nearly continual rise all year long, and in premarket trading today, PYPL shares have rocketed into blue skies, setting a new annual high with each uptick.

As we often do in these post-earnings beat gap-up situations, we’ll identify a set of options contracts in the PYPL chain to observe as things kick off this morning, in this case, the PYPL Weekly $71-72.50 Calls* for potential quick strike trades today.

*Important: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.



AcelRx Pharmaceuticals, Inc. ACRX

ACRX recently fell off a cliff after the FDA rejected the company’s NDA for its Dsuvia drug, however ACRX believes it can meet the accompanying guidelines to eventually submit a successful application. We did alert that event in last Friday’s report, and meanwhile, the stock is gapping up this morning after having seen and bounced off of new annual lows yesterday. 

Recovering even a fraction of the ground it lost last week, could spell significant upswings for ACRX in coming sessions.


Extended Watchlist:
 AUPH, GALT, HMNY, INFI, ONVO, NEOT, BAC,